Results 171 to 180 of about 3,930 (204)

CEA, CYFRA21-1 and SCC in non-small cell lung cancer

Lung Cancer, 1995
CEA, SCC and CYFRA 21-1 were measured in samples of serum coming from 105 'Non small cell lung cancer' (NSCLC) patients. The present study has been carried out to compare these markers, to analyse their prognostic significance and to determine the best combination of tumor markers.
D, Moro, D, Villemain, J P, Vuillez, C A, Delord, C, Brambilla   +4 more
openaire   +2 more sources

Perfluorosulfonic acid polymer based eATRP for ultrasensitive detection of CYFRA21-1 DNA

Analytical Methods, 2020
The sensitive detection of biomarker cytokeratin fragment antigen 21-1 (CYFRA21-1) is crucial for early diagnosis and screening of non-small cell lung cancer (NSCLC).
Kai Hu, Jiamin Cheng, Jinge Li, Shan Ye, Huaixia Yang, Yanju Liu, Jinming Kong   +6 more
openaire   +2 more sources

Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines

Lung Cancer, 2000
The CYFRA 21-1 assay which detects cytokeratin 19 (CK19) fragment is widely used as a tumor marker for lung cancer. However, the reason why some lung cancer cell lines release CK19 fragment in culture supernatants and others do not, remains unclear. It was hypothesized that the release of CK19 fragment may be elucidated by the expression of mRNA for ...
K, Dohmoto, S, Hojo, J, Fujita, Y, Ueda, S, Bandoh, Y, Yamaji, Y, Ohtsuki, N, Dobashi, J, Takahara   +8 more
openaire   +2 more sources

Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma

Annals of Surgical Oncology, 2007
A high serum cytokeratin 19 fragment (CYFRA21-1) concentration in patients with various cancers is associated with poor prognosis. This study aimed to establish the clinical significance of preoperative serum CYFRA21-1 in patients with intrahepatic cholangiocarcinoma.CYFRA21-1, carcinoembryonic antigen (CEA), and carbohydrate antigen (CA) 19-9 ...
Takahiro, Uenishi, Osamu, Yamazaki, Hiromu, Tanaka, Shigekazu, Takemura, Takatsugu, Yamamoto, Shogo, Tanaka, Shuhei, Nishiguchi, Shoji, Kubo   +7 more
openaire   +2 more sources

[Clinical usefulness of serum CYFRA21-1 in colorectal cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 1996
Serum CYFRA21-1 levels were studied in 127 cases of colorectal cancer. The positive rates for serum CYFRA21-1 were 34.6% in primary colorectal cancer. There was a significant correlation between the positive rates of serum CYFRA21-1 and liver metastases, peritoneal dissemination, lymph node metastases, or clinical stage.
T, Miyashita, G, Nishimura, Y, Michiwa, T, Sato, K, Tsugawa, S, Fushida, K, Sugiyama, T, Fujimura, Y, Yonemura, K, Miwa, I, Miyazaki   +10 more
openaire   +1 more source

SERUM CYTOKERATIN-19 MEASURED BY CYFRA21-1 ASSAY IN PATIENTS WITH GASTROINTESTINAL AND GYNECOLOGIC MALIGNANCY

International Journal of Oncology, 1994
The serum fragment of cytokeratin 19 was measured in 130 patients with gastrointestinal, breast and gynecologic cancer and 62 patients with benign disease using CYFRA21-1 immunoradiometric assay. Patients with advanced cancer showed the highest level of serum CYFRA21-1.
H, Sakahara, T, Kousaka, H, Kobayashi, Z, Yao, M, Imamura, T, Mori, J, Konishi   +6 more
openaire   +2 more sources

CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma

Biomarkers, 2010
The increasing panel of systemic therapies enables the individual management of lung cancer patients, even in advanced stages. However, predictive tools indicating the efficacy of chemoradiotherapy (CRT) are badly needed.To determine the tumour markers for predicting the therapeutic effect in non-small-cell lung carcinoma (NSCLC) patients treated with ...
Juan, Wang, Yan, Yi, Baosheng, Li, Zhongtang, Wang, Hongfu, Sun, Peiliang, Zhang, Wei, Huang   +6 more
openaire   +2 more sources

Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer

Cancer Letters, 2015
In this study, we screened 381 miRNAs by RT-qPCR in serum samples of 44 NSCLC patients and 22 healthy individuals to identify altered miRNAs, and validated the results in a training and test cohorts with 300 serum samples (178 NSCLC and 122 healthy individuals).
Chengcheng, Zhou, Zhaoli, Chen, Jingsi, Dong, Jiagen, Li, Xuejiao, Shi, Nan, Sun, Mei, Luo, Fang, Zhou, Fengwei, Tan, Jie, He   +9 more
openaire   +2 more sources

LDH, CA125, and CYFRA21-1 in tuberculous pleural effusion

Medicina Clínica (English Edition), 2022
openaire   +3 more sources

[Diagnostic value of combined detection of CYFRA21-1 and TSGF in nasopharyngeal carcinoma].

Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology, 2006
To study the diagnostic value of cytokeraetin 19 fragment (CYFRA21-1) and tumor supplied group factors (TSGF) in nasopharyngeal carcinoma (NPC).Serum levels of CYFRA21-1 and TSGF in 82 patients with NPC, 25 patients with benign nasopharyngeal disease and 50 normal controls were measured by electrochemiluminescence immuno-assay.The levels of CYFRA21-1 ...
Lingsha, Huang, Wencheng, Huang, Yanhua, Chen   +2 more
openaire   +1 more source